In the past, the study of KS pathogenesis has been hampered by the lack of in vitro and in vivo experimental systems. Recently, the establishment of long-term cultures of KS spindle cells and the development of animal models have allowed a variety of studies on the pathobiology of the disease. The results from these studies, reviewed herein, indicate that KS is a cytokine-mediated disease and that inflammatory and angiogenic cytokines and the HIV-1 Tat protein cooperate in its induction and progression in HIV-1-infected individuals
The Tat protein of HIV-1, a transactivator of viral gene expression, is released by acutely infected...
The African endemic Kaposi’s sarcoma (EnKS) is still prevalent in sub-Saharan Africa (SSA) despite h...
The Tat protein of HIV-1, a transactivator of viral gene expression, is released by acutely infected...
In the past, the study of KS pathogenesis has been hampered by the lack of in vitro and in vivo expe...
Kaposi's Sarcoma (KS) is a tumor of mesenchymal origin of unclear etiology and pathogenesis. The epi...
Kaposi's sarcoma (KS) is a mesenchymal tumor of unclear etiopathogenesis. The epidemic form of KS oc...
Kaposi's sarcoma (KS) arises more frequently in homosexual and bisexual men than in other groups of ...
Kaposi's sarcoma (KS) is an angioproliferative disease occurring in several different clinical-epide...
Kaposi's sarcoma (KS) is the most common malignancy that affects patients with HIV infection. Consid...
Kaposi's sarcoma (KS) is an angioproliferative disease occurring in several different clinical-e...
Abstract: Kaposi’s sarcoma (KS)-associated her-pesvirus is associated with the proliferative/maligna...
AbstractHIV infection strongly predisposes people to Kaposi's sarcoma, a complex proliferative lesio...
The Tat protein of HIV-1, a transactivator of viral gene expression, is released by acutely infected...
The African endemic Kaposi’s sarcoma (EnKS) is still prevalent in sub-Saharan Africa (SSA) despite h...
The Tat protein of HIV-1, a transactivator of viral gene expression, is released by acutely infected...
In the past, the study of KS pathogenesis has been hampered by the lack of in vitro and in vivo expe...
Kaposi's Sarcoma (KS) is a tumor of mesenchymal origin of unclear etiology and pathogenesis. The epi...
Kaposi's sarcoma (KS) is a mesenchymal tumor of unclear etiopathogenesis. The epidemic form of KS oc...
Kaposi's sarcoma (KS) arises more frequently in homosexual and bisexual men than in other groups of ...
Kaposi's sarcoma (KS) is an angioproliferative disease occurring in several different clinical-epide...
Kaposi's sarcoma (KS) is the most common malignancy that affects patients with HIV infection. Consid...
Kaposi's sarcoma (KS) is an angioproliferative disease occurring in several different clinical-e...
Abstract: Kaposi’s sarcoma (KS)-associated her-pesvirus is associated with the proliferative/maligna...
AbstractHIV infection strongly predisposes people to Kaposi's sarcoma, a complex proliferative lesio...
The Tat protein of HIV-1, a transactivator of viral gene expression, is released by acutely infected...
The African endemic Kaposi’s sarcoma (EnKS) is still prevalent in sub-Saharan Africa (SSA) despite h...
The Tat protein of HIV-1, a transactivator of viral gene expression, is released by acutely infected...